Using Epsom salt compresses to relieve postpartum perineal pain
If the Use of Epsom Salt (magnesium Sulfate) Compresses 25% Effective in Relieving Perineal Pain in Immediate Postpartum Patients?
PHASE2 · Université de Sherbrooke · NCT06393608
This study is testing if Epsom salt compresses can help women feel less pain in their perineal area after giving birth.
Quick facts
| Phase | PHASE2 |
|---|---|
| Study type | Interventional |
| Enrollment | 90 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Université de Sherbrooke (other) |
| Locations | 4 sites (Chicoutimi, Quebec and 3 other locations) |
| Trial ID | NCT06393608 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to evaluate the effectiveness of compresses soaked in 25% magnesium sulfate for alleviating perineal pain in women after vaginal childbirth. Participants will be randomly assigned to receive either the magnesium sulfate treatment or a placebo (water-soaked compresses) during their hospital stay. They will apply the compresses for 15 minutes, up to four times a day, and record their pain levels in a diary. The study will take place in four hospitals in Quebec, Canada, and will involve a total of 104 participants.
Who should consider this trial
Good fit: Ideal candidates are women who have just given birth vaginally and report perineal or vulvar pain of 3/10 or more.
Not a fit: Patients who have undergone a cesarean section or have hemodynamic instability will not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could provide significant pain relief for postpartum women experiencing perineal discomfort.
How similar studies have performed: While the use of magnesium sulfate for this purpose has not been extensively studied, similar approaches in pain management have shown promise in other contexts.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Planned hospital stay at the mother-child unit of the Hôpital de Chicoutimi, Hôpital Charles-Le Moyne, or Hôpital Honoré-Mercier * Vaginal delivery with or without perineal tear, any degree of tear, including episiotomies * Obtaining consent for the study * Languages spoken: French, English or both Exclusion Criteria: * Hemodynamic instability * Surgical procedure such as a cesarean section * Transfer to another hospital * Transfer to another care unit * Chronic use of narcotics * Inability to complete the logbook * Unsigned consent form
Where this trial is running
Chicoutimi, Quebec and 3 other locations
- Hôpital de Chicoutimi — Chicoutimi, Quebec, Canada (NOT_YET_RECRUITING)
- Hôpital Brome-Missisquoi-Perkins — Cowansville, Quebec, Canada (NOT_YET_RECRUITING)
- Hôpital Charles Lemoyne — Greenfield Park, Quebec, Canada (RECRUITING)
- Hôpital Honoré-Mercier — Saint-Hyacinthe, Quebec, Canada (NOT_YET_RECRUITING)
Study contacts
- Principal investigator: Antoine Roger — Université de Sherbrooke
- Study coordinator: Antoine Roger, MD, B.sc
- Email: Antoine.Roger@USherbrooke.ca
- Phone: 450 466-5630
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Perineal Injury, Pain